In the fourth quarter of the financial year 2025 (Q4FY25), a significant financial setback has been reported, primarily due to a substantial increase in the impairment of financial instruments. The impairment on financial instruments witnessed a remarkable surge, escalating to ₹919.2 crore. This figure represents a notable jump from ₹187.8 crore recorded in the corresponding period of the previous year and ₹554.6 crore in the preceding quarter. This sharp spike in impairment has had a direct impact on the company’s financial performance during this crucial quarter.
Adding to the financial challenges, the company also faced a decline in its net interest income (NII). In Q4FY25, the NII dropped by 6.7% on a year – on – year basis. It fell to ₹1,464.3 crore, as compared to ₹1,569 crore in the same period of the previous year. This decline in NII is a matter of concern for the company, as it is an important component of its revenue stream and reflects the effectiveness of its lending and investment activities.
Despite these financial headwinds, the company has taken a positive step by declaring an interim dividend. Shareholders have something to look forward to, with the company announcing an interim dividend of ₹0.50 per equity share, which has a face value of ₹2. The record date for determining the eligible shareholders to receive this dividend has been set as Thursday, May 15, 2025. This dividend declaration may help boost investor confidence and provide some relief to shareholders amidst the company’s recent financial performance trends.
Related topics
- China’s State Banks Actively Absorb Offshore Yuan Liquidity, Increasing Costs for Shorting Currency
- JPY Gains Momentum Amid US-China Trade Uncertainty and Diverging Central Bank Policies
- USD/JPY Under Pressure as Safe-Haven Yen Strengthens Amid Trade Tensions
